After three-plus years, the FDA's device center has published the final version of a guidance for medical device reports (MDR), a document that seems little changed from the draft version. The agency held onto language found in the 2013 draft regarding investigational device exemptions and contract manufacturing arrangements, which critics of the draft had argued would lead to useless duplication of reports of device-related adverse events.
Read More
